BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 20552623)

  • 1. The NCI Alliance for Nanotechnology in Cancer: achievement and path forward.
    Ptak K; Farrell D; Panaro NJ; Grodzinski P; Barker AD
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(5):450-60. PubMed ID: 20552623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highlights of recent developments and trends in cancer nanotechnology research--view from NCI Alliance for Nanotechnology in Cancer.
    Hull LC; Farrell D; Grodzinski P
    Biotechnol Adv; 2014; 32(4):666-78. PubMed ID: 23948249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small scale cancer fighters. Advances in nanotechnology offer hope for more effective and less toxic treatments.
    Printz C
    Cancer; 2008 Oct; 113(7):1497-8. PubMed ID: 18800391
    [No Abstract]   [Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NCI Alliance for Nanotechnology in Cancer - from academic research to clinical interventions.
    Grodzinski P; Liu CH; Hartshorn CM; Morris SA; Russell LM
    Biomed Microdevices; 2019 Mar; 21(2):32. PubMed ID: 30904965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanotechnology platforms and physiological challenges for cancer therapeutics.
    Kim KY
    Nanomedicine; 2007 Jun; 3(2):103-10. PubMed ID: 17442621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is cancer nanotechnology?
    Grobmyer SR; Iwakuma N; Sharma P; Moudgil BM
    Methods Mol Biol; 2010; 624():1-9. PubMed ID: 20217585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging implications of nanotechnology on cancer diagnostics and therapeutics.
    Cuenca AG; Jiang H; Hochwald SN; Delano M; Cance WG; Grobmyer SR
    Cancer; 2006 Aug; 107(3):459-66. PubMed ID: 16795065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanotechnology for sensing, imaging, and treating cancer.
    Panchapakesan B; Wickstrom E
    Surg Oncol Clin N Am; 2007 Apr; 16(2):293-305. PubMed ID: 17560513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NIH and NCI support for development of novel therapeutics in gynecologic cancer: a user's guide.
    Minig L; Trimble EL; Birrer MJ; Kim KY; Takebe N; Abrams JS
    Gynecol Oncol; 2010 Feb; 116(2):177-80. PubMed ID: 19889449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New science-based endpoints to accelerate oncology drug development.
    Kelloff GJ; Sigman CC
    Eur J Cancer; 2005 Mar; 41(4):491-501. PubMed ID: 15737552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New frontiers in nanotechnology for cancer treatment.
    Alexis F; Rhee JW; Richie JP; Radovic-Moreno AF; Langer R; Farokhzad OC
    Urol Oncol; 2008; 26(1):74-85. PubMed ID: 18190835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Closing Remarks.
    Reed E
    Oncologist; 1996; 1(4):276-277. PubMed ID: 10388002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five strategies for accelerating the war on cancer in an era of budget deficits.
    Doroshow JH; Croyle RT; Niederhuber JE
    Oncologist; 2009 Feb; 14(2):110-6. PubMed ID: 19147688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NCI support for particle therapy: past, present, future.
    Deye JA
    Health Phys; 2012 Nov; 103(5):662-6. PubMed ID: 23032896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Trials: A Congressional Focus of Need.
    Coltman CA
    Oncologist; 1997; 2(4):VII-VIII. PubMed ID: 10388059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National Cancer Institute Alliance for nanotechnology in cancer-Catalyzing research and translation toward novel cancer diagnostics and therapeutics.
    Hartshorn CM; Russell LM; Grodzinski P
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Nov; 11(6):e1570. PubMed ID: 31257722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotechnology: emerging tool for diagnostics and therapeutics.
    Chakraborty M; Jain S; Rani V
    Appl Biochem Biotechnol; 2011 Nov; 165(5-6):1178-87. PubMed ID: 21847590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
    Gralow J; Ozols RF; Bajorin DF; Cheson BD; Sandler HM; Winer EP; Bonner J; Demetri GD; Curran W; Ganz PA; Kramer BS; Kris MG; Markman M; Mayer RJ; Raghavan D; Ramsey S; Reaman GH; Sawaya R; Schuchter LM; Sweetenham JW; Vahdat LT; Davidson NE; Schilsky RL; Lichter AS;
    J Clin Oncol; 2008 Jan; 26(2):313-25. PubMed ID: 18086794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.